BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kudelka MR, Stowell SR, Cummings RD, Neish AS. Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD. Nat Rev Gastroenterol Hepatol. 2020;17:597-617. [PMID: 32710014 DOI: 10.1038/s41575-020-0331-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Xi, Hofmann L, Alter T, Einspanier R, Bereswill S, Heimesaat MM, Gölz G, Sharbati S. The glycosyltransferase ST3GAL2 is regulated by miR-615-3p in the intestinal tract of Campylobacter jejuni infected mice. Gut Pathog 2021;13:42. [PMID: 34183045 DOI: 10.1186/s13099-021-00437-1] [Reference Citation Analysis]
2 Werny L, Colmorgen C, Becker-Pauly C. Regulation of meprin metalloproteases in mucosal homeostasis. Biochim Biophys Acta Mol Cell Res 2022;1869:119158. [PMID: 34626680 DOI: 10.1016/j.bbamcr.2021.119158] [Reference Citation Analysis]
3 Sun Z, Ji G, Wang G, Wei L, Zhang Y, Lu H. One step carboxyl group isotopic labeling for quantitative analysis of intact N-glycopeptides by mass spectrometry. Chem Commun (Camb) 2021;57:4154-7. [PMID: 33908447 DOI: 10.1039/d1cc00197c] [Reference Citation Analysis]
4 Zeng F, Shi Y, Wu C, Liang J, Zhong Q, Briley K, Xu B, Huang Y, Long M, Wang C, Chen J, Tang Y, Li X, Jiang M, Wang L, Xu Q, Yang L, Chen P, Duan S, Xie J, Li C, Wu Y. A drug-free nanozyme for mitigating oxidative stress and inflammatory bowel disease. J Nanobiotechnology 2022;20:107. [PMID: 35246140 DOI: 10.1186/s12951-022-01319-7] [Reference Citation Analysis]
5 Sun TY, Li YQ, Zhao FQ, Sun HM, Gao Y, Wu B, Yang S, Ji FQ, Zhou DS. MiR-1-3p and miR-124-3p synergistically damage the intestinal barrier in the aging colon. J Crohns Colitis 2021:jjab179. [PMID: 34628497 DOI: 10.1093/ecco-jcc/jjab179] [Reference Citation Analysis]
6 Zhong H, Li Y, Huang Y, Zhao R. Metal-organic frameworks as advanced materials for sample preparation of bioactive peptides. Anal Methods 2021;13:862-73. [PMID: 33543184 DOI: 10.1039/d0ay02193h] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Petrov VA, Sharapov SZ, Shagam L, Nostaeva AV, Pezer M, Li D, Hanić M, Mcgovern D, Louis E, Rahmouni S, Lauc G, Georges M, Aulchenko YS. Association Between Human Gut Microbiome and N-Glycan Composition of Total Plasma Proteome. Front Microbiol 2022;13:811922. [DOI: 10.3389/fmicb.2022.811922] [Reference Citation Analysis]
8 Wang SL, Wang Y, Wu L, Cai YY, Wang ZC, Alolga RN, Qi LW, Li B, Huang FQ. Paired Derivatization Approach with H/D-Labeled Hydroxylamine Reagents for Sensitive and Accurate Analysis of Monosaccharides by Liquid Chromatography Tandem Mass Spectrometry. Anal Chem 2022. [PMID: 35171578 DOI: 10.1021/acs.analchem.1c04924] [Reference Citation Analysis]
9 Malaker SA, Quanico J, Raffo-Romero A, Kobeissy F, Aboulouard S, Tierny D, Bertozzi CR, Fournier I, Salzet M. On-tissue spatially resolved glycoproteomics guided by N-glycan imaging reveal global dysregulation of canine glioma glycoproteomic landscape. Cell Chem Biol 2021:S2451-9456(21)00224-5. [PMID: 34102146 DOI: 10.1016/j.chembiol.2021.05.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Xu Z, Zhang Y, Ocansey DKW, Wang B, Mao F. Glycosylation in Cervical Cancer: New Insights and Clinical Implications. Front Oncol 2021;11:706862. [PMID: 34485140 DOI: 10.3389/fonc.2021.706862] [Reference Citation Analysis]
11 Sha J, Zhang R, Fan J, Gu Y, Pan Y, Han J, Xu X, Ren S, Gu J. The B-Cell-Specific Ablation of B4GALT1 Reduces Cancer Formation and Reverses the Changes in Serum IgG Glycans during the Induction of Mouse Hepatocellular Carcinoma. Cancers 2022;14:1333. [DOI: 10.3390/cancers14051333] [Reference Citation Analysis]
12 Visser EA, Moons SJ, Timmermans SBPE, de Jong H, Boltje TJ, Büll C. Sialic acid O-acetylation: From biosynthesis to roles in health and disease. J Biol Chem 2021;297:100906. [PMID: 34157283 DOI: 10.1016/j.jbc.2021.100906] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Morosi LG, Cutine AM, Cagnoni AJ, Manselle-Cocco MN, Croci DO, Merlo JP, Morales RM, May M, Pérez-Sáez JM, Girotti MR, Méndez-Huergo SP, Pucci B, Gil AH, Huernos SP, Docena GH, Sambuelli AM, Toscano MA, Rabinovich GA, Mariño KV. Control of intestinal inflammation by glycosylation-dependent lectin-driven immunoregulatory circuits. Sci Adv 2021;7:eabf8630. [PMID: 34144987 DOI: 10.1126/sciadv.abf8630] [Reference Citation Analysis]
14 Zeng J, Aryal RP, Stavenhagen K, Luo C, Liu R, Wang X, Chen J, Li H, Matsumoto Y, Wang Y, Wang J, Ju T, Cummings RD. Cosmc deficiency causes spontaneous autoimmunity by breaking B cell tolerance. Sci Adv 2021;7:eabg9118. [PMID: 34613773 DOI: 10.1126/sciadv.abg9118] [Reference Citation Analysis]
15 Zhang Y, Wang L, Ocansey DKW, Wang B, Wang L, Xu Z. Mucin-Type O-Glycans: Barrier, Microbiota, and Immune Anchors in Inflammatory Bowel Disease. J Inflamm Res 2021;14:5939-53. [PMID: 34803391 DOI: 10.2147/JIR.S327609] [Reference Citation Analysis]
16 Wang G, Yuan J, Luo J, Ocansey DKW, Zhang X, Qian H, Xu W, Mao F. Emerging role of protein modification in inflammatory bowel disease. J Zhejiang Univ Sci B 2022;23:173-88. [PMID: 35261214 DOI: 10.1631/jzus.B2100114] [Reference Citation Analysis]
17 Leite-Gomes E, Dias AM, Azevedo CM, Santos-Pereira B, Magalhães M, Garrido M, Amorim R, Lago P, Marcos-Pinto R, Pinho SS. Bringing to Light the Risk of Colorectal Cancer in Inflammatory Bowel Disease: Mucosal Glycosylation as a Key Player. Inflamm Bowel Dis 2021:izab291. [PMID: 34849933 DOI: 10.1093/ibd/izab291] [Reference Citation Analysis]
18 Magalhães A, Duarte HO, Reis CA. The role of O-glycosylation in human disease. Mol Aspects Med 2021;79:100964. [PMID: 33775405 DOI: 10.1016/j.mam.2021.100964] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Huang Y, Wang MM, Yang ZZ, Ren Y, Zhang W, Sun ZR, Nie SN. Pretreatment with intestinal trefoil factor alleviates stress-induced gastric mucosal damage via Akt signaling. World J Gastroenterol 2020; 26(48): 7619-7632 [PMID: 33505140 DOI: 10.3748/wjg.v26.i48.7619] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
20 Kudelka MR, Li Z, Chernova TA, Smith DF, Song X, Cummings RD, Ju T. Cellular O-Glycome Reporter/Amplification (CORA): Analytical and Preparative Tools to Study Mucin-Type O-Glycans of Living Cells. Curr Protoc 2021;1:e142. [PMID: 34101390 DOI: 10.1002/cpz1.142] [Reference Citation Analysis]
21 van Muijlwijk GH, van Mierlo G, Jansen PWTC, Vermeulen M, Bleumink-Pluym NMC, Palm NW, van Putten JPM, de Zoete MR. Identification of Allobaculum mucolyticum as a novel human intestinal mucin degrader. Gut Microbes 2021;13:1966278. [PMID: 34455931 DOI: 10.1080/19490976.2021.1966278] [Reference Citation Analysis]
22 Pan S, Chen R. Pathological implication of protein post-translational modifications in cancer. Molecular Aspects of Medicine 2022. [DOI: 10.1016/j.mam.2022.101097] [Reference Citation Analysis]
23 Qiu P, Ishimoto T, Fu L, Zhang J, Zhang Z, Liu Y. The Gut Microbiota in Inflammatory Bowel Disease. Front Cell Infect Microbiol 2022;12:733992. [DOI: 10.3389/fcimb.2022.733992] [Reference Citation Analysis]
24 Chen Y, Cui W, Li X, Yang H. Interaction Between Commensal Bacteria, Immune Response and the Intestinal Barrier in Inflammatory Bowel Disease. Front Immunol 2021;12:761981. [PMID: 34858414 DOI: 10.3389/fimmu.2021.761981] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Bergstrom K, Xia L. The barrier and beyond: Roles of intestinal mucus and mucin-type O-glycosylation in resistance and tolerance defense strategies guiding host-microbe symbiosis. Gut Microbes 2022;14:2052699. [PMID: 35380912 DOI: 10.1080/19490976.2022.2052699] [Reference Citation Analysis]
26 Chen L, Wang J, Yi J, Liu Y, Yu Z, Chen S, Liu X. Increased mucin-degrading bacteria by high protein diet leads to thinner mucus layer and aggravates experimental colitis. J Gastroenterol Hepatol 2021. [PMID: 34050560 DOI: 10.1111/jgh.15562] [Reference Citation Analysis]
27 Yau YY, Wasinger VC, Hirten RP, Chuang E, Huntsman M, Stylli J, Shimizu J, Yajnik V, Smith J, Lee SN, Singh S, Wahl C, Leong RW, Sands BE. Current Trends in IBD-Development of Mucosal-Based Biomarkers and a Novel Minimally Invasive Recoverable Sampling System. Inflamm Bowel Dis 2021;27:S17-24. [PMID: 34791290 DOI: 10.1093/ibd/izab179] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Yu W, Wang G, Lu C, Liu C, Jiang L, Jiang Z, Liang Z, Wang X, Qin Z, Yan J. Pharmacological mechanism of Shenlingbaizhu formula against experimental colitis. Phytomedicine 2022;98:153961. [PMID: 35121392 DOI: 10.1016/j.phymed.2022.153961] [Reference Citation Analysis]
29 Hadji H, Bouchemal K. Advances in the Treatment of Inflammatory Bowel Disease: Focus on Polysaccharide Nanoparticulate Drug Delivery Systems. Advanced Drug Delivery Reviews 2022. [DOI: 10.1016/j.addr.2021.114101] [Reference Citation Analysis]
30 Lin L, Li Y, Zhou G, Wang Y, Li L, Han J, Chen M, He Y, Zhang S. Multi-Omics Analysis of Western-style Diet Increased Susceptibility to Experimental Colitis in Mice. JIR 2022;Volume 15:2523-37. [DOI: 10.2147/jir.s361039] [Reference Citation Analysis]